Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2013

View Archived Issues

Evaluation of an inhalable gene therapy for the treatment of PAH

Researchers at AiCuris synthesize new monobactam derivatives for bacterial infections

Team of researchers at Galecto Biotech patents novel galectin inhibitors

Researchers present phase III results for 99mTc tilmanocept in melanoma patients

Cellceutix to initiate Prurisol clinical trial

Zebrafish model mimics human affective disorders

Phase II trial finds fluorescein an alternative for SLN identification in melanoma

FDA approves ViiV Healthcare's Tivicay for treatment of HIV-1

Identification of a rare genetic deletion with the development of neurodevelopmental disorders

Amarantus reports encouraging preclinical data for MANF in retinitis pigmentosa

MatinasBioPharma receives financing for omega-3 candidate

Cystinosis Research Foundation issues six grants in the U.S. and Canada

U.K.'s MRC supports Cyclacel's seliciclib study in RA

Novel KLB1 inhibitors disclosed by Novartis

Chinese group presents novel agents for cancer and other disorders

Shenogen Pharma Group synthesizes novel agents for cancer

Vifor Pharma and Zeria Pharmaceutical enter licensing agreement for Ferinject

Canadian government provides funding to expand HIV antibody program

Lundbeck divulges novel PDE9 inhibitors for neurodegenerative disorders

Sunovion Pharmaceuticals and Afraxis form drug discovery partnership

ImmuPharma provides update on IPP-204106 cancer program

Methoxyflurane trial meets primary and secondary endpoints

MM-111 receives FDA orphan drug status for gastric and esophageal cancers

Hanmi gains U.S. approval for incrementally modified drug Esomezol

Thomson Reuters, PathGroup and GenoSpace collaborate on personalized oncology medicine service

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...